SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Drugs that provide the splice of life: Motor neurons relay signals from the nervous system to muscle fibers. In patients with spinal muscular atrophy, a protein required for the survival of these neurons is deficient or missing altogether, so the neurons gradually die and the patients' muscles waste away. The disease is currently untreatable. Naryshkin et al. discovered small-molecule drugs that cause cells to produce the missing protein by altering how a specific mRNA is put together, or “spliced” (see the Perspective by Vigevani and Valcárcel). When the researchers used the drugs to treat diseased mice, the mice showed marked improvement in muscle mass, motor function, and survival. Science , this issue p. 688 ; see also p. 624
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These screens, which are typically conducted in genetically engineered cell lines that harbour the target of interest, led to the discovery of the splice modulators risdiplam106 and branaplam107 for the treatment of spinal muscular atrophy”
From Human disease models in drug development (2023) · cites this paper as [106]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
GMAP: A genomic mapping and alignment program for mRNA and EST sequences
Wu, T. D., & Watanabe, C. K. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti310 · Cited by 2,354
Fast and SNP-tolerant detection of complex variants and splicing in short reads
Wu, T. D., & Nacu, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq057 · Cited by 1,894
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E. S., Schroth, M., Simonds, A., Wong, B., Aloysius, A., Morrison, L., Main, M., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 961
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Cited by
Items 501–533 of 533
Fullenkamp, C. R., Mehdi, S., Jones, C. P., Tenney, L., Pichling, P., Prestwood, P. R., Ferré-D’Amaré, A. R., Tiwary, P., & Schneekloth, J. S. (2025) · Angewandte Chemie · doi:10.1002/ange.202505971 · Cited by 1
Roy, S., Liu, Y., & Wu, P. (2025) · ChemBioChem · doi:10.1002/cbic.202500421
Harris, A. W., Scott, R. C., & Butchbach, M. E. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-12194-1
Chao, K.-H., Mao, A., Liu, A., Salzberg, S. L., & Pertea, M. (2025) · eLife · doi:10.7554/elife.107454.2 · Cited by 1
MEDICAMENTOUS THERAPY OF THE DUCHENNE MUSCULAR DYSTROPHY AND THE SPINAL MUSCULAR ATROPHY
Sokolova, M. G., Никишина, О. А., Maretina, M. A., Kiselev, A., Лобзин, С. В., & Zuev, A. A. (2017) · Medical academic journal · doi:10.17816/maj17124-33
Correcting CFTR mRNA splicing defects with the plant cytokine kinetin and its analogues
Rimoldi, V., Soldà, G., Capalbo, A., Saba, E., Giannone, V., Capurro, V., Lentini, L., Melfi, R., Lazzeri, M., Porcaro, L., et al. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.11.006
Comprehensive medicinal chemistry IV–High throughput screening technologies
Loria, P. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00087-x
LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II
Yu, L., Wang, Y., King, R., Myers, G., Deng, K., McGee, B. M., Friedman, A. D., Balbin-Cuesta, G., Lin, Z., Drysdale, C. M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adt4859 · Cited by 1
Méthodes de synthèse de ligands et sondes chimiques d'ARN
Fleurisson, C. (2023) · theses.fr (ABES) · doi:10.70675/9501ea44ze354z4e26zb92bzcd007e6cf9c9
Hattori, H., Otsu, M., Imai, K., Narahara, M., Kondo, J., Shino, A., & Morishita, E. C. (2026) · Small Science · doi:10.1002/smsc.202600007
Jiao, Y., Zhao, J., Fu, B., Dong, P., Qian, X., Liu, T., & Qin, W. (2026) · RSC Advances · doi:10.1039/d6ra00871b
Neurodegenerative spliceosomopathies
Mavillonio, A., Rizzini, D., Detassis, S., & Denti, M. A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1787859
“…treatment with small-molecule splicing modifiers significantly increased full-length SMN levels and improved motor function and survival in SMA mouse models, with transcriptomic analyses revealing a partial normalization of aberrant RNA processing and splicing alterations (Naryshkin et al., 2014).”
Emerging therapeutic strategies and clinical management of spinal muscular atrophy
DAS, S. M., Mishra, A., & Palei, N. N. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00280-7 · Cited by 1
Liguori, M., Consiglio, A., D’Errico, E., Antonacci, Y., Coffa, M., Introna, A., & Simone, I. L. (2026) · Brain Sciences · doi:10.3390/brainsci16060643
“In this longitudinal, 12-month observation on adult SMA subjects treated with Ris-diplam, the increase in SMN transcripts was verified, thus supporting the therapeutic efficiency of the molecule.”
Sutton, E. R., Beauvais, A., Yaworski, R., McMillan, H. J., & Kothary, R. (2026) · Annals of Neurology · doi:10.1002/ana.78302
Ruwald, S., Vankova, A., Hanschmann, F., Menedo, C., Wittig, S., Stephan, M. L., Dreilich, V., Ruetze, S., Smith, A. K., Sowoidnich, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.14.744836
Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS
Heinsinger, N. M., Wang, Y., Grauer, S. M., Zhang, Z., Wong, J., Simov, V., Bukhtiyarova, M., Ai, X., Parish, C. A., Klein, R. M., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107582
Strizhakova, O. M., Сергеевич, П. А., Bahareva, Y., Kazarov, A. A., Lyagoskin, I. V., Bocharova, E., Anisimov, R., Gladchenko, Y. A., Kholod, N., Kirik, I., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14091994 · Cited by 1
The rapid emergence of small molecule RNA modulator hit discovery: unlocking the potential
Moore, R., Bonetti, A., Cox, R. J., Geschwindner, S., Giurrandino, M., Cuesta, S. M., & Schießer, S. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2736534
Bai, Z., & Chen, A. A. (2026) · Molecules · doi:10.3390/molecules31193428
The Phenotypic Hit-to-Probe Challenge
Herschel, S., Ullrich, T. S., Schmidt, E., Quancard, J., & Schade, D. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02122
BindingDB Entry 50018999: Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery.
BindingDB (2024) · UC San Diego · doi:10.7270/q2wq081p
BindingDB (2024) · UC San Diego · doi:10.7270/q22r3x4x
BindingDB (2024) · UC San Diego · doi:10.7270/q20v8j1b
BindingDB Entry 50014978: Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.
BindingDB (2023) · UC San Diego · doi:10.7270/q2xd15jr
Modulation of pre-mRNA splicing by small molecules
Arecco, N., & Valcárcel, J. (2026) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2026.103423
Metadata
- Authors
- Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., Chen, G., Zhang, N., Gabbeta, V., Vazirani, P., Bhattacharyya, A., Furia, B., Risher, N., Sheedy, J., Kong, R., Ma, J., Turpoff, A., Lee, C.-S., Zhang, X., Moon, Y.-C., Trifillis, P., Welch, E. M., Colacino, J. M., Babiak, J., Almstead, N. G., Peltz, S. W., Eng, L. A., Chen, K. S., Mull, J. L., Lynes, M. S., Rubin, L. L., Fontoura, P., Santarelli, L., Haehnke, D., McCarthy, K. D., Schmucki, R., Ebeling, M., Sivaramakrishnan, M., Ko, C.-P., Paushkin, S. V., Ratni, H., Gerlach, I., Ghosh, A., & Metzger, F.
- Affiliations
- PTC Therapeutics (United States) (US)
- University of Southern California (US)
- Spinal Muscular Atrophy Foundation (US)
- Harvard University (US)
- F. Hoffmann-La Roche AG (CH)
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.
- Corresponding author
- Peltz, Stuart W.
- Metzger, Friedrich
- ORCID
- Naryshkin, Nikolai A.
- Weetall, Marla
- Narasimhan, Jana
- Zhao, Xin
- Ling, Karen K. Y.
- Chen, Guangming
- Zhang, Nanjing
- Sheedy, Josephine
- Kong, Ronald
- Ma, Jiyuan
- Moon, Young-Choon
- Welch, Ellen M.
- Colacino, Joseph M.
- Peltz, Stuart W.
- Chen, Karen S.
- Rubin, Lee L.
- Fontoura, Paulo
- Ebeling, Martin
- Ko, Chien-Ping
- Paushkin, Sergey V.
- Ratni, Hasane
- Metzger, Friedrich
- Venue
- Science
- Published
- 2014-08-08
- Volume
- 345
- Issue
- 6197
- Pages
- 688-693
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1992985034
- Cited by
- 524
- References
- 56
- Citations by year
- 2026: 19 · 2025: 40 · 2024: 47 · 2023: 33 · 2022: 50 · 2021: 54 · 2020: 34 · 2019: 47 · 2018: 50 · 2017: 44 · 2016: 59 · 2015: 35 · 2014: 12
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- spinal muscular atrophy, SMN2, SMN1, alternative splicing, small molecules, SMN protein, motor function, lifespan extension, neuromuscular degeneration, compound screening
- MeSH terms
- Administration, Oral, Animals, Cells, Cultured, Coumarins, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Longevity, Muscular Atrophy, Spinal, Pyrimidinones, RNA, Messenger, Sequence Deletion, Alternative Splicing, Isocoumarins, Mice, Small Molecule Libraries, Survival of Motor Neuron 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.